
About RNAi2009 Sponsors

Gold Sponsor and Exhibitor
Thermo Scientific is the world's leading brand of innovative Dharmacon RNA interference research products. We supply the highest quality custom RNA oligonucleotides and siRNA, as well as siRNA transfection reagents and innovative ready-to-use SMARTvector™ Lentiviral shRNA Particles. Thermo Scientific offers guaranteed pre-designed Dharmacon siRNA reagents targeting all unique human, mouse, and rat genes in the NCBI RefSeq database. These genome-wide reagents include the market-leading ON-TARGETplus™ siRNA, proven to reduce off-targets by up to 90%. In addition to our groundbreaking research tools, we now provide RNAi library screening and microRNA expression analysis services.
ABgene ® – now sold as Thermo Scientific - manufactures and develops high-performance QPCR reagents and amplification plastics that facilitate reproducible, sensitive and accurate quantization of all nucleic acid targets. Through constant customer feedback and an innovative approach to product development, Thermo Scientific has developed a portfolio of industry-leading products.

Gold Sponsor and Exhibitor
QIAGEN is a global leader in sample and assay technologies for life sciences, applied testing and molecular diagnostics. Its products are considered standards that comprise complete solutions from sample to result. QIAGEN offers the broadest portfolio of molecular diagnostic assays for infectious diseases including the only test for human papillomavirus (HPV), which has both FDA and CE-approvals. The company has developed a comprehensive portfolio of more than 500 proprietary, consumable products and instruments for sample collection, nucleic acid and protein handling, separation, purification, detection, and open and target specific assays. QIAGEN’s products are sold to academic research markets, leading pharmaceutical and biotechnology companies, applied testing customers (focused on forensics, veterinary diagnostics, biodefense, and industrial applications) as well as to molecular diagnostics laboratories. QIAGEN’s global headquarters are located in Hilden, Germany.
Silver Sponsor and Exhibitor
Eurogentec, located in Liège, Belgium, provides innovative services and
products for the Molecular Life Science community. We have been supplying
our European customers for more than 20 years, specialising in the
customised products such as Oligonucleotides (specialising in the synthesis
of all oligo types [DNA, RNA, LNA, siRNA, qPCR probes] with one of the
widest ranges of modifications and purifications on the market), Custom Gene
Synthesis (capabilities of >10,000bp), Custom Antibodies (anti-protein /
anti-peptide polyclonal and monoclonal) and flexible Real Time qPCR
solutions (reagents, plates, controls, etc.).

Exhibitor
Integrated DNA Technologies (IDT) is the largest supplier of custom
nucleic acids in the United States. Serving the areas of academic
research, biotechnology, clinical diagnostics and pharmaceutical
development, IDT's primary business is the manufacturing of DNA and RNA
oligonucleotides (oligos) for research applications. Basic product
offerings include DNA oligos, RNA oligos, and over one hundred chemical
modifications, ranging from short single-stranded oligos to 10,000 base
pair synthetic genes. IDT products support DNA sequencing, DNA
amplification, SNP detection, microarray analysis, expression profiling,
gene quantification, and functional genomics.
IDT recently announced the launch of its Screening Dicer-substrate RNAi
(DsiRNA) duplexes for cost-effective, high speed siRNA.
In addition to its corporate headquarters in Coralville, Iowa, IDT has
production centers in San Diego, California and Leuven, Belgium.

Delegate Badge Sponsor
Coley Pharmaceutical GmbH – A Pfizer Company: Pfizer’s new Biotherapeutics and Bioinnovation Center (BBC) is a federation of small biotech research units, each focused on a novel and growing area of biotechnology, and utilizing it to develop new medicines . Coley Pharmaceutical GmbH in Düsseldorf, Germany, was the latest addition to the BBC in 2008, and is a pioneer in developing a class of drug candidates called TLR Therapeutics. These nucleic acid therapeutics work by stimulating important immune system receptors, known as Toll-like receptors (TLRs). Founded in 1997, Coley centers on nucleic acid-related technologies such as oligonucleotide chemistry, delivery and immunology. Together with Pfizer’s Research Technology Center (RTC) in Cambridge, MA, USA, Coley today focuses on unlocking the full potential of RNAi therapeutics. By bringing together a large set of diverse disciplines, Coley and the RTC develop the therapeutic applications of RNAi and other nucleic acid therapies, and apply innovative science to solve the difficulties inherent in nucleic acid therapeutics.

Poster Award Sponsor
Nucleic Acids Research (NAR) is a fully Open Access journal, providing rapid publication of leading edge research. NAR publishes the results of leading edge research into physical, chemical, biochemical and biological aspects of nucleic acids and proteins involved in nucleic acid metabolism and/or interactions. For more information, please visit www.nar.oxfordjournals.org.

Exhibitor
OUP publishes some of the most respected scientific books and journals in the world, including Bioinformatics, an official journal of the ISCB. The top-ranked journal publishes high quality research with a focus on new developments in genome bioinformatics and computational biology. OUP also publishes Nucleic Acids Research, Briefings in Bioinformatics, and Briefings in Functional Genomicsand Proteomics. New to Oxford in 2009 is Database: The Journal of Biological Databases and Curation.
Exhibitor
Exiqon combines leading-edge scientific expertise in gene expression with our proprietary LNA™ technology. Our products, services and scientific staff enable life science researchers to make groundbreaking discoveries. Moreover, we are addressing the unmet need for a new approach to the diagnosis of cancer.
Exiqon markets its products directly on www.exiqon.com, or through distributors, and partners its proprietary Locked Nucleic Acids (LNA) and Anthraquinone (AQ) technologies through industry leaders. Exiqon is located in the Medicon Valley area of Copenhagen, Denmark.

Exhibitor
Agilent Technologies is a leading supplier of life science technologies, providing solutions for gene expression, proteomics, metabolomics and informatics that optimize sensitivity and workflow productivity. Key products include: whole genome and custom microarrays, scanners; HPLC, LC/MS/MS and HPLC-Chip/MS; ion trap and TOF mass spectrometers; lab-on-a-chip products; reagents; and data analysis software. Information about Agilent is available on the web at www.agilent.com.

Dinner Wine Sponsor
RXi Pharmaceuticals is a leader in Next Generation RNA targeting, including its proprietary rxRNA™ discovery platform and delivery technologies, for the treatment of human diseases. RXi is a biopharmaceutical company engaged in the discovery, development and commercialization of proprietary therapeutics based on RNA interference (RNAi). RXi Pharmaceuticals believes it is well positioned to compete successfully in the RNAi therapeutics market with its strong technology platform, broad and early intellectual property position, a management team that is experienced in commercializing products, and accomplished scientific advisors, including Dr. Craig Mello, recipient of the 2006 Nobel Prize for his co-discovery of RNAi.

|